[Peroral contraception (2): pharmacodynamics and clinical experiences].
D002584:Cervix Uteri / Q000378:metabolism; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004717:Endometrium / Q000187:drug effects; D004967:Estrogens / Q000009:adverse effects; D004997:Ethinyl Estradiol / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects; D009277:Nandrolone / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D010053:Ovary / Q000187:drug effects; D010902:Pituitary Gland / Q000187:drug effects
D003276:Contraceptives, Oral; D004967:Estrogens; D004997:Ethinyl Estradiol; D009277:Nandrolone
Peroral antikonception (2): verkningsmekanism och klinisk rutin.